The Made in Chelsea star, 34, underwent an emergency C-section in November 2021 while giving birth to their son, Leo.

The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...

For decades, people in this area have been dealing with unusually high rates of serious health problems, such as multiple sclerosis, ulcerative colitis, Crohn’s disease, and various ...

Reports Q4 revenue $4.2B, consensus $4.12B. Richard Francis, Teva‘s (TEVA) President and CEO, said: “2024 marked a transformative year for ...

NET PROFIT FORECAST: Takeda is expected to post a 59% drop in net profit to 43.58 billion yen, equivalent to $280.2 million, for the three months ended Dec. 31, according to a poll of analysts by data ...

Eagles star Jake Waterman says it’s “no coincidence” he’s playing career-best footy after his life-changing illness. Watch every match of the 2025 AAMI Community Series Live & ad-break free during ...

French researchers have discovered that sensitivity to the emulsifier E466 (Carboxymethylcellulose), a food additive used in ...

Shares of Teva Pharmaceutical Industries ( TEVA -13.03%) were slipping Wednesday. The company's stock lost 13.5% as of 1:15 p ...

Mark Genovese: Crohn’s disease is a chronic, inflammatory bowel disease associated with progressive bowel damage, disability, ...

Teva reported fourth-quarter revenue of $4.2 billion, beating analyst estimates of $4.13 billion, according to Benzinga Pro.

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA has opened the reporting season for Israeli companies by ...

Operator Hello, and welcome to the fourth quarter and full year 2024 Teva Pharmaceutical Industries earnings conference call.